(Q47580283)

4 February 2018

title

The role of economic evaluation in mental health care (English)

1 reference

4 February 2018

1 reference

1 reference

B Singh

1

1 reference

4 February 2018

G Hawthorne

series ordinal

2

1 reference

4 February 2018

T Vos

series ordinal

3

1 reference

4 February 2018

publication date

1 February 2001

1 reference

4 February 2018

Australian and New Zealand Journal of Psychiatry

published in

1 reference

4 February 2018

volume

35

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

104-117

1 reference

4 February 2018

Economic evaluations and interventions for children and adolescents with mental health problems.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Measuring the economic costs of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Systematic review of the effectiveness of planned short hospital stays for mental health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Mental health care costs: paucity of measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Economic evaluation of mental health care interventions. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

DRGs and Australian psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

The evaluation of mental health care systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Getting the cost right in cost-effectiveness analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Social comparison in adjustment to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Assessment of outcomes of health intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

The cost of comprehensive care of people with schizophrenia living in the community. A cost evaluation from a German catchment area

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2001.00845.X

10.1046/J.1440-1614.2001.00845.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018